ArticleArquivos brasileiros de cardiologia2021

Cost-Effectiveness Analysis of Evolocumab Therapy in Patients at High Risk of Cardiovascular Events in the Context of the Brazilian Unified Health System.

Luiza Latado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.